Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Gregory M Glenn. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Gregory M Glenn har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:NVAX / Novavax, Inc. | President, R&D | 18 339 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Gregory M Glenn. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp NVAX / Novavax, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i NVAX / Novavax, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i NVAX / Novavax, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Gregory M Glenn som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −2 432 | 18 339 | −11,71 | 6,52 | −15 857 | 119 570 | |
2023-03-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 6 298 | 20 771 | 43,52 | 6,52 | 41 063 | 135 427 | |
2023-03-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 1 000 | 14 473 | 7,42 | 6,50 | 6 500 | 94 074 | |
2023-03-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 2 000 | 13 473 | 17,43 | 7,04 | 14 088 | 94 904 | |
2023-03-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 3 000 | 11 473 | 35,41 | 7,48 | 22 454 | 85 870 | |
2022-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 033 | 8 009 | −11,42 | 17,23 | −17 799 | 137 995 | |
2022-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 3 100 | 9 042 | 52,17 | ||||
2022-03-14 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 18 894 | 18 894 | |||||
2022-03-14 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 28 341 | 28 341 | |||||
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −662 | 7 944 | −7,69 | |||
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 024 | 0 | −100,00 | |||
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −27 | 5 663 | −0,47 | 180,62 | −4 877 | 1 022 857 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −206 | 5 690 | −3,49 | 179,58 | −36 993 | 1 021 799 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −103 | 5 896 | −1,72 | 178,99 | −18 436 | 1 055 341 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −223 | 5 999 | −3,58 | 176,83 | −39 432 | 1 060 775 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −67 | 6 222 | −1,07 | 175,89 | −11 785 | 1 094 407 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −137 | 6 289 | −2,13 | 174,65 | −23 927 | 1 098 386 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −91 | 6 426 | −1,40 | 173,29 | −15 770 | 1 113 578 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −248 | 6 517 | −3,67 | 172,38 | −42 750 | 1 123 382 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −254 | 6 765 | −3,62 | 171,47 | −43 553 | 1 159 990 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −213 | 7 019 | −2,95 | 170,46 | −36 309 | 1 196 492 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −117 | 7 232 | −1,59 | 168,82 | −19 752 | 1 220 919 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 662 | 7 349 | 9,90 | 46,00 | 30 452 | 338 054 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 024 | 6 687 | 18,08 | 27,60 | 28 262 | 184 561 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −3 100 | 6 200 | −33,33 | ||||
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 498 | 5 663 | −20,92 | 168,43 | −252 308 | 953 819 | |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 3 100 | 7 161 | 76,34 | ||||
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 82 500 | −9,09 | |||
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 061 | −2,40 | 182,96 | −18 296 | 743 001 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −853 | 4 161 | −17,01 | 182,30 | −155 498 | 758 532 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 5 014 | −9,07 | 180,29 | −90 147 | 903 994 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 5 514 | −8,31 | 179,36 | −89 680 | 988 991 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 6 014 | −7,68 | 178,21 | −89 104 | 1 071 743 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 6 514 | −10,94 | 176,20 | −140 956 | 1 147 734 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −900 | 7 314 | −10,96 | 175,13 | −157 619 | 1 280 917 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 8 214 | −2,38 | 173,14 | −34 627 | 1 422 131 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 8 414 | −2,32 | 171,30 | −34 260 | 1 441 318 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 8 614 | −4,44 | 168,77 | −67 508 | 1 453 785 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 9 014 | −3,22 | 167,06 | −50 118 | 1 505 879 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 9 314 | −3,12 | 165,80 | −49 739 | 1 544 230 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 9 614 | −3,03 | 164,77 | −49 430 | 1 584 067 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 9 914 | −1,98 | 162,82 | −32 565 | 1 614 247 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 10 114 | −2,88 | 161,63 | −48 490 | 1 634 759 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 10 414 | −2,80 | 160,52 | −48 157 | 1 671 690 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 10 714 | −2,72 | 158,42 | −47 527 | 1 697 347 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 11 014 | −1,78 | 157,02 | −31 404 | 1 729 418 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 11 214 | −2,61 | 156,24 | −46 873 | 1 752 112 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 11 514 | −0,86 | 154,38 | −15 438 | 1 777 531 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −397 | 11 614 | −3,31 | 153,53 | −60 951 | 1 783 081 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 12 011 | −0,83 | 151,85 | −15 185 | 1 823 870 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 12 111 | −1,62 | 150,30 | −30 059 | 1 820 223 |
2021-12-09 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 12 311 | 203,15 | 19,08 | 157 410 | 234 894 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 90 750 | −8,33 | |||
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 061 | −2,40 | 211,75 | −21 175 | 859 917 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −551 | 4 161 | −11,69 | 210,57 | −116 026 | 876 199 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −879 | 4 712 | −15,72 | 209,81 | −184 419 | 988 604 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 450 | 5 591 | −20,59 | 208,78 | −302 727 | 1 167 273 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −353 | 7 041 | −4,77 | 207,19 | −73 139 | 1 458 849 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −439 | 7 394 | −5,60 | 206,06 | −90 462 | 1 523 641 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −465 | 7 833 | −5,60 | 203,79 | −94 764 | 1 596 320 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −715 | 8 298 | −7,93 | 202,37 | −144 692 | 1 679 233 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −338 | 9 013 | −3,61 | 201,23 | −68 015 | 1 813 661 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −717 | 9 351 | −7,12 | 200,40 | −143 690 | 1 873 979 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −678 | 10 068 | −6,31 | 199,25 | −135 091 | 2 006 048 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −836 | 10 746 | −7,22 | 198,17 | −165 670 | 2 129 532 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −356 | 11 582 | −2,98 | 197,31 | −70 242 | 2 285 220 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −518 | 11 938 | −4,16 | 195,87 | −101 460 | 2 338 281 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 12 456 | −1,58 | 194,62 | −38 923 | 2 424 124 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −222 | 12 656 | −1,72 | 192,58 | −42 752 | 2 437 244 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −4 | 12 878 | −0,03 | 191,29 | −765 | 2 463 433 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −121 | 12 882 | −0,93 | 189,98 | −22 987 | 2 447 306 |
2021-12-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 13 003 | 173,57 | 19,08 | 157 410 | 248 097 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −1 377 | 30 296 | −4,35 | |||
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 083 | 45 834 | −4,35 | |||
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −647 | 4 753 | −11,98 | 217,97 | −141 027 | 1 036 011 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −38 | 5 400 | −0,70 | 217,97 | −8 283 | 1 177 038 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 377 | 5 438 | 33,91 | 5,95 | 8 193 | 32 356 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −114 | 4 061 | −2,73 | 221,24 | −25 222 | 898 467 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −155 | 4 175 | −3,58 | 220,22 | −34 134 | 919 426 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −412 | 4 330 | −8,69 | 219,25 | −90 333 | 949 372 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −626 | 4 742 | −11,66 | 218,25 | −136 627 | 1 034 962 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −331 | 5 368 | −5,81 | 217,36 | −71 946 | 1 166 790 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −260 | 5 699 | −4,36 | 216,19 | −56 209 | 1 232 051 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −185 | 5 959 | −3,01 | 215,00 | −39 776 | 1 281 206 |
2021-11-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 083 | 6 144 | 51,29 | 5,95 | 12 394 | 36 557 |
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 99 000 | −7,69 | |||
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 4 061 | −4,69 | 203,62 | −40 723 | 826 881 |
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −870 | 4 261 | −16,96 | 202,65 | −176 302 | 863 475 |
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −722 | 5 131 | −12,34 | 201,48 | −145 468 | 1 033 787 |
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 600 | 5 853 | −21,47 | 200,55 | −320 887 | 1 173 845 |
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 387 | 7 453 | −15,69 | 199,51 | −276 720 | 1 486 945 |
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 271 | 8 840 | −12,57 | 198,47 | −252 252 | 1 754 454 |
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 400 | 10 111 | −12,16 | 197,44 | −276 419 | 1 996 337 |
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 11 511 | −6,50 | 196,43 | −157 143 | 2 261 092 |
2021-11-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 12 311 | 203,15 | 19,08 | 157 410 | 234 894 |
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 107 250 | −7,14 | |||
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 4 061 | −12,87 | 170,94 | −102 562 | 694 174 |
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −4 352 | 4 661 | −48,29 | 170,26 | −740 977 | 793 588 |
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 326 | 9 013 | −12,83 | 168,91 | −223 969 | 1 522 350 |
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 472 | 10 339 | −12,46 | 167,95 | −247 225 | 1 736 455 |
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 11 811 | −4,06 | 166,89 | −83 446 | 1 971 161 |
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 12 311 | 203,15 | 19,08 | 157 410 | 234 894 |
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −662 | 8 606 | −7,14 | |||
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −521 | 1 024 | −33,72 | |||
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 183 | 4 061 | −22,56 | 172,02 | −203 496 | 698 560 |
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 662 | 5 244 | 14,45 | 46,00 | 30 452 | 241 224 |
2021-11-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 521 | 4 582 | 12,83 | 27,60 | 14 380 | 126 463 |
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 115 500 | −6,67 | |||
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 061 | −2,40 | 171,48 | −17 148 | 696 380 |
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 4 161 | −8,77 | 170,55 | −68 219 | 709 648 |
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 478 | 4 561 | −24,47 | 169,54 | −250 582 | 773 279 |
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −672 | 6 039 | −10,01 | 168,46 | −113 204 | 1 017 323 |
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 000 | 6 711 | −22,96 | 167,76 | −335 517 | 1 125 827 |
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 800 | 8 711 | −17,12 | 166,55 | −299 783 | 1 450 783 |
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 400 | 10 511 | −11,75 | 165,72 | −232 013 | 1 741 921 |
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 11 911 | −3,25 | 164,23 | −65 693 | 1 956 173 |
2021-11-12 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 12 311 | 203,15 | 19,08 | 157 410 | 234 894 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 123 750 | −6,25 | |||
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 061 | −2,40 | 197,51 | −19 751 | 802 088 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 4 161 | −4,59 | 196,24 | −39 248 | 816 555 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −378 | 4 361 | −7,98 | 195,54 | −73 913 | 852 739 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 4 739 | −5,95 | 194,40 | −58 320 | 921 262 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 5 039 | −7,35 | 193,16 | −77 262 | 973 308 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 5 439 | −1,81 | 190,29 | −19 029 | 1 034 987 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 5 539 | −5,14 | 188,33 | −56 499 | 1 043 160 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 5 839 | −4,89 | 187,26 | −56 177 | 1 093 392 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 6 139 | −7,53 | 186,09 | −93 047 | 1 142 431 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −302 | 6 639 | −4,35 | 184,82 | −55 815 | 1 227 011 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 6 941 | −10,33 | 183,58 | −146 860 | 1 274 194 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 7 741 | −7,19 | 182,58 | −109 547 | 1 413 339 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −670 | 8 341 | −7,44 | 181,55 | −121 637 | 1 514 294 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 9 011 | −6,24 | 180,41 | −108 248 | 1 625 704 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −900 | 9 611 | −8,56 | 179,09 | −161 180 | 1 721 223 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 200 | 10 511 | −10,25 | 178,12 | −213 749 | 1 872 263 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 11 711 | −4,87 | 177,12 | −106 269 | 2 074 194 |
2021-11-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 12 311 | 203,15 | 19,08 | 157 410 | 234 894 |
2021-11-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −26 | 4 061 | −0,64 | 152,16 | −3 956 | 617 940 |
2021-11-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −16 | 4 087 | −0,39 | 149,64 | −2 394 | 611 579 |
2021-11-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −353 | 4 103 | −7,92 | 148,99 | −52 592 | 611 286 |
2021-11-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −138 | 4 456 | −3,00 | 148,08 | −20 435 | 659 851 |
2021-11-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −108 | 4 594 | −2,30 | 146,51 | −15 823 | 673 049 |
2021-11-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −39 | 4 702 | −0,82 | 145,41 | −5 671 | 683 707 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −1 378 | 31 673 | −4,17 | |||
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 132 000 | −5,88 | |||
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 084 | 47 917 | −4,17 | |||
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −637 | 4 741 | −11,84 | 134,99 | −85 989 | 639 988 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −61 | 5 378 | −1,12 | 134,99 | −8 234 | 725 976 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 378 | 5 439 | 33,93 | 5,95 | 8 199 | 32 362 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 000 | 4 061 | −19,76 | 135,16 | −135 160 | 548 885 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 700 | 5 061 | −25,14 | 133,82 | −227 499 | 677 278 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 134 | 6 761 | −31,67 | 133,02 | −416 876 | 899 330 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 000 | 9 895 | −23,26 | 131,91 | −395 730 | 1 305 249 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 500 | 12 895 | −10,42 | 130,93 | −196 402 | 1 688 403 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 14 395 | 134,26 | 19,08 | 157 410 | 274 657 |
2021-10-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 084 | 6 145 | 51,32 | 5,95 | 12 400 | 36 563 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 140 250 | −5,56 | |||
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 061 | −2,40 | 172,03 | −17 203 | 698 614 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 4 161 | −8,77 | 171,02 | −68 406 | 711 593 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 4 561 | −6,17 | 169,85 | −50 954 | 774 671 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 4 861 | −14,13 | 168,49 | −134 794 | 819 044 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 366 | 5 661 | −19,44 | 167,08 | −228 235 | 945 854 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 000 | 7 027 | −12,46 | 165,98 | −165 984 | 1 166 370 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 400 | 8 027 | −14,85 | 164,85 | −230 786 | 1 323 231 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 9 427 | −4,07 | 163,01 | −65 203 | 1 536 672 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −893 | 9 827 | −8,33 | 162,05 | −144 710 | 1 592 455 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 591 | 10 720 | −12,92 | 161,00 | −256 152 | 1 725 928 |
2021-10-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 12 311 | 203,15 | 19,08 | 157 410 | 234 894 |
2021-10-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −662 | 9 268 | −6,67 | |||
2021-10-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −521 | 1 545 | −25,22 | |||
2021-10-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 183 | 4 061 | −22,56 | 170,00 | −201 110 | 690 370 |
2021-10-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 662 | 5 244 | 14,45 | 46,00 | 30 452 | 241 224 |
2021-10-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 521 | 4 582 | 12,83 | 27,60 | 14 380 | 126 463 |
2021-10-14 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 148 500 | −5,26 | |||
2021-10-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 4 061 | −6,88 | 166,78 | −50 033 | 677 280 |
2021-10-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −392 | 4 361 | −8,25 | 165,70 | −64 954 | 722 614 |
2021-10-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 4 753 | −14,41 | 164,50 | −131 601 | 781 875 |
2021-10-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 858 | 5 553 | −33,98 | 163,38 | −466 945 | 907 259 |
2021-10-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 900 | 8 411 | −25,64 | 162,45 | −471 103 | 1 366 361 |
2021-10-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 000 | 11 311 | −8,12 | 161,58 | −161 582 | 1 827 654 |
2021-10-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 12 311 | 203,15 | 19,08 | 157 410 | 234 894 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 250 | 156 750 | −5,00 | |||
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 4 061 | −4,69 | 183,14 | −36 628 | 743 732 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −179 | 4 261 | −4,03 | 182,05 | −32 587 | 775 704 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 4 440 | −8,26 | 180,41 | −72 164 | 801 020 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 4 840 | −7,63 | 179,39 | −71 755 | 868 236 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 5 240 | −10,27 | 178,37 | −107 024 | 934 676 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 5 840 | −4,89 | 177,31 | −53 194 | 1 035 510 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 6 140 | −7,53 | 176,49 | −88 244 | 1 083 636 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 6 640 | −8,29 | 175,32 | −105 194 | 1 164 147 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −700 | 7 240 | −8,82 | 174,12 | −121 887 | 1 260 660 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −700 | 7 940 | −8,10 | 172,70 | −120 891 | 1 371 249 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 200 | 8 640 | −20,30 | 171,86 | −378 088 | 1 484 855 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 471 | 10 840 | −11,95 | 170,80 | −251 240 | 1 851 421 |
2021-10-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 250 | 12 311 | 203,15 | 19,08 | 157 410 | 234 894 |
2021-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −16 | 4 061 | −0,39 | 211,39 | −3 382 | 858 455 |
2021-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −40 | 4 077 | −0,97 | 210,16 | −8 406 | 856 824 |
2021-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −118 | 4 117 | −2,79 | 209,27 | −24 694 | 861 572 |
2021-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −117 | 4 235 | −2,69 | 207,99 | −24 335 | 880 857 |
2021-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −280 | 4 352 | −6,04 | 207,01 | −57 962 | 900 898 |
2021-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −16 | 4 632 | −0,34 | 205,01 | −3 280 | 949 606 |
2021-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −55 | 4 648 | −1,17 | 203,94 | −11 217 | 947 901 |
2021-10-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −51 | 4 703 | −1,07 | 202,84 | −10 345 | 953 944 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −1 377 | 33 051 | −4,00 | |||
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 083 | 50 001 | −4,00 | |||
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −648 | 4 754 | −12,00 | 231,04 | −149 714 | 1 098 364 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −36 | 5 402 | −0,66 | 231,04 | −8 317 | 1 248 078 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 377 | 5 438 | 33,91 | 5,95 | 8 193 | 32 356 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −95 | 4 061 | −2,29 | 248,13 | −23 573 | 1 007 672 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −56 | 4 156 | −1,33 | 243,98 | −13 663 | 1 013 983 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −99 | 4 212 | −2,30 | 240,37 | −23 796 | 1 012 420 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −124 | 4 311 | −2,80 | 239,04 | −29 641 | 1 030 506 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −57 | 4 435 | −1,27 | 237,29 | −13 526 | 1 052 381 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −98 | 4 492 | −2,14 | 236,30 | −23 157 | 1 061 437 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −203 | 4 590 | −4,24 | 235,10 | −47 726 | 1 079 120 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −217 | 4 793 | −4,33 | 233,87 | −50 750 | 1 120 936 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −262 | 5 010 | −4,97 | 233,24 | −61 108 | 1 168 516 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −318 | 5 272 | −5,69 | 232,00 | −73 775 | 1 223 088 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −272 | 5 590 | −4,64 | 231,07 | −62 850 | 1 291 663 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −225 | 5 862 | −3,70 | 229,99 | −51 748 | 1 348 215 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −57 | 6 087 | −0,93 | 228,12 | −13 003 | 1 388 566 |
2021-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 083 | 6 144 | 51,29 | 5,95 | 12 394 | 36 557 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −662 | 9 930 | −6,25 | |||
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −521 | 2 066 | −20,14 | |||
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −45 | 4 061 | −1,10 | 234,73 | −10 563 | 953 230 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −65 | 4 106 | −1,56 | 233,02 | −15 146 | 956 778 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −165 | 4 171 | −3,81 | 232,01 | −38 282 | 967 730 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −196 | 4 336 | −4,32 | 231,08 | −45 292 | 1 001 975 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −152 | 4 532 | −3,25 | 230,10 | −34 976 | 1 042 832 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −96 | 4 684 | −2,01 | 228,93 | −21 977 | 1 072 305 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −99 | 4 780 | −2,03 | 227,89 | −22 561 | 1 089 298 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −204 | 4 879 | −4,01 | 226,66 | −46 238 | 1 105 867 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −99 | 5 083 | −1,91 | 225,70 | −22 344 | 1 147 217 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −62 | 5 182 | −1,18 | 224,59 | −13 925 | 1 163 831 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 662 | 5 244 | 14,45 | 46,00 | 30 452 | 241 224 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 521 | 4 582 | 12,83 | 27,60 | 14 380 | 126 463 |
2021-09-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −62 | 4 061 | −1,50 | 244,02 | −15 130 | 990 986 |
2021-09-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 123 | −2,37 | 242,63 | −24 263 | 1 000 349 |
2021-09-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −209 | 4 223 | −4,72 | 241,59 | −50 492 | 1 020 224 |
2021-09-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −175 | 4 432 | −3,80 | 240,58 | −42 102 | 1 066 266 |
2021-09-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −359 | 4 607 | −7,23 | 239,66 | −86 039 | 1 104 125 |
2021-09-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −320 | 4 966 | −6,05 | 238,72 | −76 391 | 1 185 495 |
2021-09-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −108 | 5 286 | −2,00 | 237,14 | −25 611 | 1 253 496 |
2021-09-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −53 | 5 394 | −0,97 | 234,64 | −12 436 | 1 265 645 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −2 754 | 34 428 | −7,41 | |||
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −4 167 | 52 084 | −7,41 | |||
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −1 296 | 5 447 | −19,22 | 230,34 | −298 521 | 1 254 662 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −72 | 6 743 | −1,06 | 230,34 | −16 584 | 1 553 183 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 754 | 6 815 | 67,82 | 5,95 | 16 386 | 40 549 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 061 | −2,40 | 241,57 | −24 157 | 981 016 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 161 | −2,35 | 240,04 | −24 004 | 998 806 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −346 | 4 261 | −7,51 | 238,62 | −82 563 | 1 016 769 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 4 607 | −7,99 | 237,34 | −94 938 | 1 093 448 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 5 007 | −3,84 | 236,13 | −47 226 | 1 182 303 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 5 207 | −7,13 | 235,27 | −94 108 | 1 225 051 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −616 | 5 607 | −9,90 | 233,89 | −144 078 | 1 311 436 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −700 | 6 223 | −10,11 | 232,89 | −163 020 | 1 449 248 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 6 923 | −5,46 | 231,35 | −92 539 | 1 601 619 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −605 | 7 323 | −7,63 | 230,52 | −139 463 | 1 688 077 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 7 928 | −2,46 | 229,35 | −45 870 | 1 818 287 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 8 128 | −1,22 | 227,74 | −22 774 | 1 851 071 |
2021-08-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 4 167 | 8 228 | 102,61 | 5,95 | 24 794 | 48 957 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 322 | 10 592 | −11,10 | |||
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −544 | 2 587 | −17,37 | |||
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −14 | 4 061 | −0,34 | 248,98 | −3 486 | 1 011 108 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −51 | 4 075 | −1,24 | 246,72 | −12 583 | 1 005 373 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −50 | 4 126 | −1,20 | 244,99 | −12 249 | 1 010 826 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −107 | 4 176 | −2,50 | 242,99 | −26 000 | 1 014 713 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −78 | 4 283 | −1,79 | 240,37 | −18 749 | 1 029 505 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −61 | 4 361 | −1,38 | 239,32 | −14 599 | 1 043 681 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −63 | 4 422 | −1,40 | 237,92 | −14 989 | 1 052 081 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −48 | 4 485 | −1,06 | 236,22 | −11 339 | 1 059 453 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −13 | 4 533 | −0,29 | 234,88 | −3 053 | 1 064 711 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −177 | 4 546 | −3,75 | 234,38 | −41 485 | 1 065 481 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −153 | 4 723 | −3,14 | 233,17 | −35 675 | 1 101 277 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −274 | 4 876 | −5,32 | 232,15 | −63 609 | 1 131 958 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −204 | 5 150 | −3,81 | 231,27 | −47 179 | 1 191 042 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −219 | 5 354 | −3,93 | 230,00 | −50 370 | 1 231 425 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −101 | 5 573 | −1,78 | 228,79 | −23 108 | 1 275 062 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −141 | 5 674 | −2,42 | 227,79 | −32 118 | 1 292 457 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −57 | 5 815 | −0,97 | 225,98 | −12 881 | 1 314 081 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −55 | 5 872 | −0,93 | 223,26 | −12 279 | 1 310 977 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 322 | 5 927 | 28,71 | 46,00 | 60 812 | 272 642 |
2021-08-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 544 | 4 605 | 13,40 | 27,60 | 15 014 | 127 098 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −56 | 2 811 | −1,95 | 229,44 | −12 849 | 644 956 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −189 | 2 867 | −6,18 | 228,60 | −43 205 | 655 396 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −306 | 3 056 | −9,10 | 227,17 | −69 515 | 694 237 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −173 | 3 362 | −4,89 | 225,91 | −39 083 | 759 517 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −63 | 3 535 | −1,75 | 224,33 | −14 133 | 793 007 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −240 | 3 598 | −6,25 | 220,66 | −52 959 | 793 949 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −56 | 3 838 | −1,44 | 218,69 | −12 247 | 839 332 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −56 | 3 894 | −1,42 | 217,44 | −12 177 | 846 711 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −126 | 3 950 | −3,09 | 214,76 | −27 059 | 848 282 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −141 | 4 076 | −3,34 | 213,55 | −30 110 | 870 411 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −63 | 4 217 | −1,47 | 211,93 | −13 352 | 893 709 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −126 | 4 280 | −2,86 | 207,63 | −26 161 | 888 656 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −135 | 4 406 | −2,97 | 206,82 | −27 920 | 911 237 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −181 | 4 541 | −3,83 | 205,66 | −37 225 | 933 914 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −119 | 4 722 | −2,46 | 204,71 | −24 360 | 966 627 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −61 | 4 841 | −1,24 | 203,39 | −12 407 | 984 619 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −199 | 4 902 | −3,90 | 202,76 | −40 348 | 993 910 |
2021-07-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −119 | 5 101 | −2,28 | 200,61 | −23 872 | 1 023 297 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −4 823 | 37 182 | −11,48 | |||
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −3 129 | 56 251 | −5,27 | |||
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 105 | 11 914 | −8,49 | |||
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −870 | 3 131 | −21,74 | |||
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −550 | 0 | −100,00 | |||
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −2 253 | 5 220 | −30,15 | 179,14 | −403 602 | 935 111 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −161 | 7 473 | −2,11 | 179,14 | −28 842 | 1 338 713 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 4 823 | 7 634 | 171,58 | 5,95 | 28 697 | 45 422 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 | 2 811 | −0,04 | 184,27 | −184 | 517 984 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −399 | 2 812 | −12,43 | 183,81 | −73 341 | 516 878 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 3 211 | −8,54 | 182,38 | −54 713 | 585 611 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −560 | 3 511 | −13,76 | 181,45 | −101 610 | 637 060 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −550 | 4 071 | −11,90 | 180,57 | −99 315 | 735 111 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −796 | 4 621 | −14,69 | 179,29 | −142 718 | 828 515 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 318 | 5 417 | −29,97 | 178,19 | −413 052 | 965 272 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −730 | 7 735 | −8,62 | 177,62 | −129 664 | 1 373 910 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 3 129 | 8 465 | 58,64 | 5,95 | 18 618 | 50 367 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 105 | 5 336 | 26,12 | 46,00 | 50 830 | 245 456 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 870 | 4 231 | 25,89 | 27,60 | 24 012 | 116 776 |
2021-07-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 550 | 3 361 | 19,57 | 27,00 | 14 850 | 90 747 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 411 | 2 811 | −46,17 | 183,28 | −441 887 | 515 199 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −4 819 | 42 005 | −10,29 | |||
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −3 124 | 59 380 | −5,00 | |||
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 101 | 13 019 | −7,80 | |||
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −868 | 4 001 | −17,83 | |||
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −623 | 0 | −100,00 | |||
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −2 254 | 5 222 | −30,15 | 187,07 | −421 656 | 976 880 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −154 | 7 476 | −2,02 | 187,07 | −28 809 | 1 398 535 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 4 819 | 7 630 | 171,43 | 5,95 | 28 673 | 45 398 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −448 | 2 811 | −13,75 | 200,00 | −89 599 | 562 194 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 3 259 | −5,78 | 198,39 | −39 678 | 646 554 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −310 | 3 459 | −8,22 | 196,65 | −60 961 | 680 204 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −188 | 3 769 | −4,75 | 195,24 | −36 704 | 735 842 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −335 | 3 957 | −7,81 | 194,35 | −65 109 | 769 062 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −557 | 4 292 | −11,49 | 193,50 | −107 777 | 830 486 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −121 | 4 849 | −2,43 | 192,14 | −23 249 | 931 691 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −261 | 4 970 | −4,99 | 191,25 | −49 916 | 950 502 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 387 | 5 231 | −20,96 | 190,31 | −263 955 | 995 491 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −53 | 6 618 | −0,79 | 189,62 | −10 050 | 1 254 885 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −8 | 6 671 | −0,12 | 187,86 | −1 503 | 1 253 196 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 810 | 6 679 | −21,32 | 187,04 | −338 547 | 1 249 259 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −37 | 8 489 | −0,43 | 186,45 | −6 899 | 1 582 780 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 | 8 526 | −0,01 | 183,53 | −184 | 1 564 812 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 3 124 | 8 527 | 57,82 | 5,95 | 18 588 | 50 736 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 101 | 5 403 | 25,59 | 46,00 | 50 646 | 248 538 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 868 | 4 302 | 25,28 | 27,60 | 23 957 | 118 735 |
2021-06-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 623 | 3 434 | 22,16 | 27,00 | 16 821 | 92 718 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −170 | 2 811 | −5,70 | 145,83 | −24 792 | 409 942 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −162 | 2 981 | −5,15 | 144,36 | −23 386 | 430 337 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −298 | 3 143 | −8,66 | 143,62 | −42 799 | 451 400 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −586 | 3 441 | −14,55 | 142,12 | −83 282 | 489 033 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 018 | 4 027 | −20,18 | 141,23 | −143 770 | 568 724 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −89 | 5 045 | −1,73 | 140,04 | −12 463 | 706 498 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −62 | 5 134 | −1,19 | 138,29 | −8 574 | 709 981 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −4 819 | 46 824 | −9,33 | |||
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −3 124 | 62 504 | −4,76 | |||
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 101 | 14 120 | −7,23 | |||
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −868 | 4 869 | −15,13 | |||
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −619 | 623 | −49,84 | |||
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −2 229 | 5 196 | −30,02 | 140,16 | −312 417 | 728 271 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −205 | 7 425 | −2,69 | 140,16 | −28 733 | 1 040 688 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 4 819 | 7 630 | 171,43 | 5,95 | 28 673 | 45 398 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 364 | 2 811 | −54,48 | 135,06 | −454 353 | 379 663 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 348 | 6 175 | −17,92 | 133,10 | −179 414 | 821 871 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 000 | 7 523 | −11,73 | 131,50 | −131 500 | 989 274 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 3 124 | 8 523 | 57,86 | 5,95 | 18 588 | 50 712 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 101 | 5 399 | 25,62 | 46,00 | 50 646 | 248 354 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 868 | 4 298 | 25,31 | 27,60 | 23 957 | 118 625 |
2021-05-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 619 | 3 430 | 22,02 | 27,00 | 16 713 | 92 610 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −494 | 2 811 | −14,95 | 224,50 | −110 905 | 631 080 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −356 | 3 305 | −9,72 | 221,67 | −78 915 | 732 622 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −437 | 3 661 | −10,66 | 220,57 | −96 390 | 807 516 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −81 | 4 098 | −1,94 | 219,17 | −17 753 | 898 177 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −153 | 4 179 | −3,53 | 218,48 | −33 428 | 913 036 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −284 | 4 332 | −6,15 | 217,22 | −61 691 | 940 999 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −417 | 4 616 | −8,29 | 216,11 | −90 117 | 997 557 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −134 | 5 033 | −2,59 | 215,01 | −28 812 | 1 082 167 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −61 | 5 167 | −1,17 | 213,79 | −13 041 | 1 104 667 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −4 819 | 51 643 | −8,53 | |||
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −3 124 | 65 628 | −4,54 | |||
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 101 | 15 221 | −6,75 | |||
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −868 | 5 737 | −13,14 | |||
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −619 | 1 242 | −33,26 | |||
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −2 260 | 5 228 | −30,18 | 202,09 | −456 723 | 1 056 527 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −142 | 7 488 | −1,86 | 202,09 | −28 697 | 1 513 250 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 4 819 | 7 630 | 171,43 | 202,09 | 973 872 | 1 541 947 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −127 | 2 811 | −4,32 | 206,82 | −26 266 | 581 371 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −83 | 2 938 | −2,75 | 205,69 | −17 073 | 604 328 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −152 | 3 021 | −4,79 | 204,71 | −31 116 | 618 437 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −391 | 3 173 | −10,97 | 204,01 | −79 767 | 647 318 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −412 | 3 564 | −10,36 | 202,85 | −83 574 | 722 953 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −833 | 3 976 | −17,32 | 201,93 | −168 208 | 802 874 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −605 | 4 809 | −11,17 | 200,77 | −121 464 | 965 490 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −959 | 5 414 | −15,05 | 199,86 | −191 670 | 1 082 065 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −717 | 6 373 | −10,11 | 198,70 | −142 465 | 1 266 290 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −873 | 7 090 | −10,96 | 197,70 | −172 594 | 1 401 709 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −560 | 7 963 | −6,57 | 196,77 | −110 190 | 1 566 868 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 3 124 | 8 523 | 57,86 | 5,95 | 18 588 | 50 712 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 101 | 5 399 | 25,62 | 46,00 | 50 646 | 248 354 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 868 | 4 298 | 25,31 | 27,60 | 23 957 | 118 625 |
2021-04-19 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 619 | 3 430 | 22,02 | 27,00 | 16 713 | 92 610 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −129 | 2 811 | −4,39 | 225,89 | −29 140 | 634 979 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −375 | 2 940 | −11,31 | 224,78 | −84 292 | 660 849 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −164 | 3 315 | −4,71 | 223,86 | −36 713 | 742 099 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −60 | 3 479 | −1,70 | 221,91 | −13 315 | 772 025 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −180 | 3 539 | −4,84 | 219,84 | −39 572 | 778 025 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −114 | 3 719 | −2,97 | 218,53 | −24 912 | 812 696 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −402 | 3 833 | −9,49 | 217,31 | −87 357 | 832 936 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −421 | 4 235 | −9,04 | 216,05 | −90 955 | 914 955 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −459 | 4 656 | −8,97 | 215,19 | −98 771 | 1 001 911 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −57 | 5 115 | −1,10 | 213,01 | −12 142 | 1 089 559 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −57 | 5 172 | −1,09 | 211,96 | −12 082 | 1 096 243 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −5 | 5 229 | −0,10 | 210,85 | −1 054 | 1 102 535 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −4 819 | 56 462 | −7,86 | |||
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −3 124 | 68 752 | −4,35 | |||
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 101 | 16 322 | −6,32 | |||
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −868 | 6 605 | −11,62 | |||
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −619 | 1 861 | −24,96 | |||
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −2 264 | 5 234 | −30,19 | 217,46 | −492 329 | 1 138 186 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −132 | 7 498 | −1,73 | 217,46 | −28 705 | 1 630 515 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 4 819 | 7 630 | 171,43 | 217,46 | 1 047 940 | 1 659 220 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 2 811 | −3,44 | 201,47 | −20 147 | 566 332 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 282 | 2 911 | −30,57 | 200,14 | −256 586 | 582 622 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 490 | 4 193 | −26,22 | 199,07 | −296 616 | 834 706 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 939 | 5 683 | −25,44 | 197,87 | −383 662 | 1 124 473 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −901 | 7 622 | −10,57 | 196,88 | −177 389 | 1 500 619 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 3 124 | 8 523 | 57,86 | 5,95 | 18 588 | 50 712 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 101 | 5 399 | 25,62 | 46,00 | 50 646 | 248 354 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 868 | 4 298 | 25,31 | 27,60 | 23 957 | 118 625 |
2021-03-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 619 | 3 430 | 22,02 | 27,00 | 16 713 | 92 610 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
M - Exercise | X | −4 819 | 61 281 | −7,29 | |||
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −3 124 | 71 876 | −4,17 | |||
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −1 101 | 17 423 | −5,94 | |||
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −868 | 7 473 | −10,41 | |||
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −619 | 2 480 | −19,97 | |||
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | X | −2 275 | 5 245 | −30,25 | 262,70 | −597 642 | 1 377 862 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
D - Sale to Issuer | X | −110 | 7 520 | −1,44 | 262,70 | −28 897 | 1 975 504 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 4 819 | 7 630 | 171,43 | 5,95 | 28 673 | 45 398 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −66 | 2 811 | −2,29 | 296,58 | −19 575 | 833 700 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −13 | 2 877 | −0,45 | 294,05 | −3 823 | 845 982 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −413 | 2 890 | −12,50 | 291,57 | −120 419 | 842 641 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −125 | 3 303 | −3,65 | 289,89 | −36 236 | 957 495 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −9 | 3 428 | −0,26 | 288,80 | −2 599 | 990 014 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −147 | 3 437 | −4,10 | 287,41 | −42 249 | 987 816 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −148 | 3 584 | −3,97 | 286,26 | −42 367 | 1 025 962 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −59 | 3 732 | −1,56 | 285,30 | −16 833 | 1 064 756 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 204 | 3 791 | −24,10 | 284,25 | −342 235 | 1 077 586 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −955 | 4 995 | −16,05 | 283,43 | −270 678 | 1 415 744 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −653 | 5 950 | −9,89 | 282,13 | −184 233 | 1 678 696 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −522 | 6 603 | −7,33 | 281,64 | −147 015 | 1 859 657 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −156 | 7 125 | −2,14 | 280,71 | −43 790 | 2 000 027 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −236 | 7 281 | −3,14 | 278,98 | −65 840 | 2 031 280 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −377 | 7 517 | −4,78 | 277,09 | −104 461 | 2 082 850 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −129 | 7 894 | −1,61 | 275,83 | −35 582 | 2 177 398 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −225 | 8 023 | −2,73 | 274,80 | −61 829 | 2 204 683 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −137 | 8 248 | −1,63 | 273,39 | −37 455 | 2 254 961 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −138 | 8 385 | −1,62 | 272,42 | −37 593 | 2 284 206 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 3 124 | 8 523 | 57,86 | 5,95 | 18 588 | 50 712 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 1 101 | 5 399 | 25,62 | 46,00 | 50 646 | 248 354 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 868 | 4 298 | 25,31 | 27,60 | 23 957 | 118 625 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 619 | 3 430 | 22,02 | 27,00 | 16 713 | 92 610 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −73 | 2 811 | −2,53 | 279,20 | −20 382 | 784 837 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −65 | 2 884 | −2,20 | 278,27 | −18 088 | 802 532 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −32 | 2 949 | −1,07 | 276,23 | −8 839 | 814 602 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −48 | 2 981 | −1,58 | 274,63 | −13 182 | 818 672 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −67 | 3 029 | −2,16 | 273,61 | −18 332 | 828 758 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −205 | 3 096 | −6,21 | 272,43 | −55 848 | 843 438 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −110 | 3 301 | −3,22 | 271,16 | −29 827 | 895 092 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −319 | 3 411 | −8,55 | 269,93 | −86 109 | 920 747 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −678 | 3 730 | −15,38 | 269,23 | −182 536 | 1 004 216 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −268 | 4 408 | −5,73 | 268,19 | −71 875 | 1 182 183 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −128 | 4 676 | −2,66 | 266,68 | −34 135 | 1 246 978 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −361 | 4 804 | −6,99 | 265,52 | −95 854 | 1 275 580 |
2021-02-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −80 | 5 165 | −1,53 | 264,09 | −21 127 | 1 364 035 |
2020-12-16 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 9 300 | 9 300 | |||||
2020-12-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 18 700 | 18 700 | |||||
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 100 | 1 561 | −41,34 | 109,21 | −120 126 | 170 470 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 145 | 2 661 | −54,17 | 108,39 | −340 889 | 288 428 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −5 789 | 5 806 | −49,93 | 107,30 | −621 140 | 622 964 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −9 915 | 11 595 | −46,09 | 106,17 | −1 052 689 | 1 231 057 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −25 000 | 75 000 | −25,00 | |||
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −551 | 21 510 | −2,50 | 117,07 | −64 548 | 2 518 081 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −951 | 22 062 | −4,13 | 116,08 | −110 346 | 2 560 891 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 003 | 23 012 | −4,17 | 115,23 | −115 521 | 2 651 710 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −401 | 24 015 | −1,64 | 113,81 | −45 639 | 2 733 226 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −727 | 24 416 | −2,89 | 113,02 | −82 148 | 2 759 594 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −216 | 25 143 | −0,85 | 111,92 | −24 124 | 2 814 095 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 343 | 25 358 | −8,46 | 110,97 | −260 024 | 2 814 074 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −8 133 | 27 701 | −22,70 | 109,98 | −894 440 | 3 046 526 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −6 661 | 35 834 | −15,68 | 109,07 | −726 546 | 3 908 346 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 739 | 42 496 | −8,09 | 108,20 | −404 560 | 4 597 948 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −276 | 46 235 | −0,59 | 107,22 | −29 560 | 4 957 349 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 25 000 | 46 510 | 116,23 | 5,95 | 148 750 | 276 734 |
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −38 588 | 0 | −100,00 | ||||
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −18 639 | 21 510 | −46,42 | 113,56 | −2 116 645 | 2 442 676 | |
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 38 588 | 40 149 | 2 472,01 | ||||
2020-08-26 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 165 000 | 165 000 | |||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −13 225 | 18 524 | −41,65 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −16 658 | 8 341 | −66,63 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −2 733 | 6 017 | −31,23 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −8 200 | 550 | −93,71 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −4 405 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −7 500 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −3 200 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
G - Gift | −1 528 | 311 | −83,09 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −525 | 1 839 | −22,21 | 146,58 | −76 954 | 269 561 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −17 151 | 2 364 | −87,89 | 146,00 | −2 504 046 | 345 144 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −31 957 | 19 515 | −62,09 | 145,00 | −4 633 765 | 2 829 675 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −6 288 | 51 472 | −10,89 | 143,94 | −905 095 | 7 408 880 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 13 225 | 57 760 | 29,70 | 46,00 | 608 350 | 2 656 960 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 16 658 | 44 535 | 59,76 | 27,60 | 459 761 | 1 229 166 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 2 733 | 27 877 | 10,87 | 27,00 | 73 791 | 752 679 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 8 200 | 25 144 | 48,39 | 27,00 | 221 400 | 678 888 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 4 405 | 16 944 | 35,13 | 36,60 | 161 223 | 620 150 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 7 500 | 12 539 | 148,84 | 25,60 | 192 000 | 320 998 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 3 200 | 5 039 | 174,01 | 50,00 | 160 000 | 251 950 | |
2020-06-22 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
M - Exercise | −16 749 | 0 | −100,00 | ||||
2020-06-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −16 749 | 1 839 | −90,11 | 59,53 | −997 103 | 109 480 | |
2020-06-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 16 749 | 18 588 | 910,77 | 42,20 | 706 808 | 784 414 | |
2020-03-10 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −760 | 0 | −100,00 | ||||
2020-03-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −294 | 1 839 | −13,78 | 12,48 | −3 669 | 22 951 | |
2020-03-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 760 | 2 133 | 55,35 | ||||
2020-02-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 1 250 | 1 373 | 1 016,26 | 3,86 | 4 825 | 5 300 | |
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 100 000 | 100 000 | |||||
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Appreciation Right |
A - Award | 66 100 | 66 100 | |||||
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 38 588 | 38 588 | |||||
2019-09-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −9 620 | 123 | −98,74 | 6,18 | −59 476 | 760 | |
2019-09-10 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −7 608 | 0 | −100,00 | ||||
2019-09-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −2 534 | 9 743 | −20,64 | 5,50 | −13 937 | 53 586 | |
2019-09-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 7 608 | 12 277 | 162,95 | ||||
2019-05-13 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 1 000 | 74 386 | 1,36 | 5,85 | 5 850 | 435 151 | |
2019-03-12 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 76 083 | 76 083 | |||||
2019-03-12 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 152 166 | 152 166 | |||||
2019-02-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 13 168 | 73 386 | 21,87 | 0,88 | 11 588 | 64 580 | |
2018-12-14 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 635 000 | 635 000 | |||||
2018-08-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 13 007 | 60 218 | 27,55 | 0,88 | 11 446 | 52 992 | |
2018-05-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 19 900 | 47 211 | 72,86 | 1,64 | 32 636 | 77 426 | |
2018-05-15 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 100 | 27 311 | 0,37 | 1,64 | 164 | 44 653 | |
2018-02-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 12 784 | 27 211 | 88,61 | 0,88 | 11 250 | 23 946 | |
2017-12-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 500 000 | 500 000 | |||||
2017-11-13 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 10 000 | 14 427 | 225,89 | 1,13 | 11 300 | 16 303 | |
2016-12-07 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 1 000 | 4 427 | 29,18 | 1,45 | 1 446 | 6 401 | |
2016-11-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 175 000 | 175 000 | |||||
2016-11-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 175 000 | 175 000 | |||||
2016-09-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 1 000 | 3 427 | 41,20 | 1,65 | 1 649 | 5 651 | |
2016-03-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
A - Award | 350 000 | 350 000 | |||||
2016-02-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 2 369 | 2 427 | 4 084,48 | 4,38 | 10 376 | 10 630 | |
2015-12-18 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
M - Exercise | −61 886 | 88 114 | −41,26 | ||||
2015-12-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −61 886 | 58 | −99,91 | 8,58 | −530 697 | 497 | |
2015-12-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 61 886 | 61 944 | 106 700,00 | 1,83 | 113 251 | 113 358 | |
2015-08-26 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
G - Gift | −1 100 | 58 | −94,99 | ||||
2015-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
M - Exercise | −15 000 | 335 000 | −4,29 | ||||
2015-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −15 000 | 1 158 | −92,83 | 13,52 | −202 743 | 15 652 | |
2015-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 15 000 | 16 158 | 1 295,34 | 2,11 | 31 650 | 34 093 | |
2015-08-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 892 | 1 158 | 335,34 | 2,28 | 2 034 | 2 640 | |
2015-03-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
G - Gift | −600 | 266 | −69,28 | ||||
2015-03-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
A - Award | 300 000 | 300 000 | |||||
2015-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 866 | 866 | 2,28 | 1 974 | 1 974 | ||
2014-09-26 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −700 | 0 | −100,00 | 4,16 | −2 916 | ||
2014-09-26 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −16 109 | 700 | −95,84 | 4,16 | −67 013 | 2 912 | |
2014-08-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 12 707 | 16 809 | 309,78 | 2,28 | 28 972 | 38 325 | |
2014-03-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −29 000 | 4 102 | −87,61 | 5,48 | −158 778 | 22 459 | |
2014-03-21 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
G - Gift | −2 000 | 33 102 | −5,70 | ||||
2014-03-07 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
A - Award | 175 000 | 889 000 | 24,51 | ||||
2014-02-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 4 102 | 31 000 | 15,25 | 2,29 | 9 394 | 70 990 | |
2013-06-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 1 000 | 31 000 | 3,33 | 1,83 | 1 830 | 56 730 | |
2013-06-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 1 000 | 30 000 | 3,45 | 2,01 | 2 010 | 60 300 | |
2013-03-06 |
|
4 | NVAX |
NOVAVAX INC
Options-right to buy |
A - Award | 150 000 | 714 000 | 26,60 | 1,83 | 274 500 | 1 306 620 | |
2012-05-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 25 000 | 29 000 | 625,00 | 1,35 | 33 750 | 39 150 | |
2012-03-08 |
|
4 | NVAX |
NOVAVAX INC
Options-right to buy |
A - Award | 150 000 | 564 000 | 36,23 | 1,28 | 192 000 | 721 920 |